Visby’s COVID-19 test gets FDA approval

About This Source - Reuters

Reuters is an international news organization owned by Thomson Reuters. It employs some 2,500 journalists and 600 photojournalists in about 200 locations worldwide. The agency was established in London in 1851 by the German-born Paul Reuter.

Recent from Reuters:

  • U.S. election race depends on who shows up on Nov. 3
  • Biden up in the polls? Weren’t they wrong in 2016?
  • Big Tech beat estimates, some stumble after hours
  • Reuters published this video item, entitled “Visby’s COVID-19 test gets FDA approval” – below is their description.

    Silicon Valley medical equipment startup Visby Medical has received Emergency Use Authorization by the U.S. Food and Drug Administration for a portable COVID-19 test kit, the first company to do so.

    Reuters YouTube Channel

    Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.

    In This Story: COVID-19

    Covid-19 is the official WHO name given to the novel coronavirus which broke out in late 2019 and began to spread in the early months of 2020.

    Symptoms of coronavirus

    The main symptoms of coronavirus are:

    • a persistent new cough (non productive, dry)
    • a high temperature (e.g. head feels warm to the touch)
    • shortness of breath (if this is abnormal for the individual, or increased)

    Latest News about Covid-19

    Below are stories from around the globe related to the 2020 outbreak of novel Coronavirus – since the WHO gave the Covid-19 naming. Most recent items are posted nearest the top.

    5 Recent Items: COVID-19

  • China Plans Way Forward: How will roadmap work in post-COVID era?
  • NBC Nightly News Broadcast (Full) – October 29th, 2020 | NBC Nightly News
  • EU to fund transfer of Covid-19 patients between countries as strain on hospitals grows
  • Queenslanders head to the polls | 7.30
  • Trump, Biden hold duelling rallies in battleground Florida as Covid-19 resurges
  • Leave a Comment